United States· US:22840-1205_36ac2a54-e52b-7e33-e063-6294a90ac0e1
Smooth Brome
A medicinal product containing bromus inermis pollen, registered in United States by Greer Laboratories, Inc..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- BROMUS INERMIS POLLEN
- Manufacturer
- Greer Laboratories, Inc.
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 4
- ndc11228401205210 mL in 1 VIAL, MULTI-DOSE (22840-1205-2)
- ndc11228401205450 mL in 1 VIAL, MULTI-DOSE (22840-1205-4)
- ndc1122840-1205-2
- ndc1122840-1205-4
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d2887c2b-1c7d-4d11-8d92-1e0bddf3491d GET /v1/drugs/d2887c2b-1c7d-4d11-8d92-1e0bddf3491d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS",
"source": "ndc",
"strength": ".1",
"substance": "BROMUS INERMIS POLLEN",
"productndc": "22840-1205",
"dosage_form": "SOLUTION",
"dea_schedule": null,
"strength_unit": "g/mL",
"application_number": "BLA101833",
"marketing_category": "BLA"
}See everything about bromus inermis pollen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.